Discover 156 paid clinical trials in Manchester, New Hampshire. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 156
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Sanford ME, Boston MA, Lebanon NH, Scarborough ME,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase 3, Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Get alerts for new trials in your area by subscribing now
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Boston MA, Worcester MA, Lebanon NH, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT06401330
Phase 3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Boston MA, Lebanon NH, Commack NY, Harrison NY,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07097142
Phase 3, Recruiting
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
for
Advanced Hepatocellular Carcinoma,
Location: Boston MA, Lebanon NH, Hartford CT, Glastonbury CT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07166406
Phase 3, Recruiting
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Location: Boston MA, Lebanon NH, Scarborough ME, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT03126916
Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Boston MA, Worcester MA, Lebanon NH, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Boston MA, Worcester MA, Lebanon NH, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Boston MA, Lebanon NH, Berlin Corners VT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Boston MA, Worcester MA, Lebanon NH, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase 3, Recruiting
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
for
Central Nervous System Nongerminomatous Germ Cell Tumor,
Location: Boston MA, Lebanon NH, Scarborough ME, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 3 - 29
Code: NCT04684368
Phase 2, Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Boston MA, Lebanon NH, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase 3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Boston MA, Worcester MA, Lebanon NH, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
for
Metastatic Malignant Neoplasm in the Lung,
Location: Boston MA, Lebanon NH, Scarborough ME, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 50
Code: NCT05235165
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Boston MA, Worcester MA, Lebanon NH, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
EIM Via the Myolex mScan as an ALS Biomarker
for
Amyotrophic Lateral Sclerosis
Location: Boston MA, Lebanon NH, Ann Arbor MI, Winston-Salem NC,
Sponsor: Beth Israel Deaconess Medical Center
Sex: All
Age: 18+
Code: NCT06491732
Recruiting
Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
for
Ulcerative Colitis
Location: Boston MA, Lebanon NH, Syracuse NY, Pittsburgh PA,